calpain inhibitor 2 has been researched along with mtt formazan in 1 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (mtt formazan) | Trials (mtt formazan) | Recent Studies (post-2010) (mtt formazan) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 690 | 1 | 136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darzynkiewicz, Z; Deptala, A; Mikulski, SM; Viera, A | 1 |
1 other study(ies) available for calpain inhibitor 2 and mtt formazan
| Article | Year |
|---|---|
Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor.
Topics: Antineoplastic Agents; Clone Cells; Colony-Forming Units Assay; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Egg Proteins; Flow Cytometry; Formazans; Humans; Leupeptins; Multienzyme Complexes; Oligopeptides; Proteasome Endopeptidase Complex; Ribonucleases; Tetrazolium Salts; Toxicity Tests; Tumor Cells, Cultured | 1998 |